BioSpace - Angiogene Inc. News, Search Jobs, Events
Angiogene Inc. 1851, Rue Sherbrooke Estate, Suite 704. Montreal Quebec H2K 4L5 Canada Phone: 514-596-1111 Fax: 514-596-1119 ...
http://www.biospace.com/company_profile.aspx?CompanyId=45621...
|
Molecular Therapy - Abstract of article: 927. Cell Therapy To ...
1Angiogene Inc., Montreal, QC, Canada; 2Division of Cardiology, Duke University Medical Center, Durham, NC. Employee iof Angiogene Inc. Top of page ...
http://www.nature.com/mt/journal/v9/n1s/abs/mt20041051a.html...
|
Text version of PowerPoint Presentation by Guy Chamberland, Ph.D.
30 Apr 2009 ... Angiogene Inc. would like to thank the FDA for allowing us to communicate our experience with drug-device combination products and how the ...
http://www.fda.gov/CombinationProducts/MeetingsConferencesWo...
|
32P-oligodeoxynucleotide-coated coils to prevent arterial ...
Angiogene Inc., Montreal, Quebec, Canada. BACKGROUND AND PURPOSE: Endovascular treatment of aneurysms with coils, a less invasive alternative to surgery, ...
http://www.ncbi.nlm.nih.gov/pubmed/15205149...
|
Meeting Transcript (HTML)
30 Apr 2009 ... I am the Vice President of Regulatory Affairs and Drug Development at Angiogene, Inc. Angiogene develops unique drug-device combination ...
http://www.fda.gov/CombinationProducts/MeetingsConferencesWo...
|
Feasibility, safety and dosimetry of intramural administration of ...
Angiogene Inc., Centre Hospitalier de l'Université de Montréal, Montreal, Quebec , Canada. PMID: 11068257 [PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/11068257...
|
Daily Dockets Entered on 11/08/02
8 Nov 2002 ... EAPE33 Angiogene Inc Vol#: 2 · EAPE34 Genzyme Corporation Vol#: 2 · EAPE35 Medtronic, Inc. Vol#: 2. EC 2 Number Not Used Vol#: 2 ...
http://www.fda.gov/ohrms/dockets/dailys/02/Nov02/110802/1108...
|
BioSpace Life Sciences Company Profiles by Industry
AnaMax, Inc. Anapharm · Anavex Life Sciences Corp. Anesiva, Inc. Angiogen · Angiogene Inc. Angiogenix, Inc. Angiosyn Inc. Antex Pharma Inc. ...
http://www.biospace.com/company_index.aspx?IndustryId=37015...
|
Daily Dockets Entered on 11/27/02
TS 3 Angiogene Inc. Vol#: 4 · TS 4 Wyeth Pharmaceuticals, Inc. Vol#: 4 · TS 5 Nephros Therapeutics, Inc. Vol#: 4 · TS 6 Carnegie Mellon University Vol#: 4 ...
http://www.fda.gov/ohrms/dockets/dailys/02/nov02/112702/1127...
|
Covalon Technologies Inc. And Perfusion Therapeutics Sign Letter ...
The technology, previously a part of Angiogene's intellectual property portfolio was assumed by Perfusion. ... 2008 BioSpace, Inc - an onTargetjobs company ...
http://www.biospace.com/news_story.aspx?NewsEntityId=24019...
|
